Format

Send to

Choose Destination
MAbs. 2015;7(1):110-9. doi: 10.4161/19420862.2014.985919.

Characterization of monoclonal antibody's binding kinetics using oblique-incidence reflectivity difference approach.

Author information

1
a Institute of Physics; Chinese Academy of Sciences ; Beijing , China.

Abstract

Monoclonal antibodies (mAbs) against human proteins are the primary protein capture reagents for basic research, diagnosis, and molecular therapeutics. The 2 most important attributes of mAbs used in all of these applications are their specificity and avidity. While specificity of a mAb raised against a human protein can be readily defined based on its binding profile on a human proteome microarray, it has been a challenge to determine avidity values for mAbs in a high-throughput and cost-effective fashion. To undertake this challenge, we employed the oblique-incidence reflectivity difference (OIRD) platform to characterize mAbs in a protein microarray format. We first systematically determined the Kon and Koff values of 50 mAbs measured with the OIRD method and deduced the avidity values. Second, we established a multiplexed approach that simultaneously measured avidity values of a mixture of 9 mono-specific mAbs that do not cross-react to the antigens. Third, we demonstrated that avidity values of a group of mAbs could be sequentially determined using a flow-cell device. Finally, we implemented a sequential competition assay that allowed us to bin multiple mAbs that recognize the same antigens. Our study demonstrated that OIRD offers a high-throughput and cost-effective platform for characterization of the binding kinetics of mAbs.

KEYWORDS:

KD; OIRD; OIRD, oblique-incidence reflectivity difference; mAb, monoclonal antibody; IP, immunoprecipitation; IHC, immunohistochemistry; ICC, immunocytochemistry; ChIP, chromatin immunoprecipitation; HuProt, human proteome microarray; ELISA, enzyme-linked immunosor; affinity; avidity; kinetics; monoclonal antibodies; protein microarrays

PMID:
25530170
PMCID:
PMC4622085
DOI:
10.4161/19420862.2014.985919
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Taylor & Francis Icon for PubMed Central
Loading ...
Support Center